Kosuke Funato

1.0k citations

16 papers · 641 indexed · h-index 12

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Cancer Research
- MicroRNA in disease regulation

Papers in ⓘ

Genetics 7
- Glioma Diagnosis and Treatment 7
- Virus-based gene therapy research 3
Geriatrics and Gerontology 2
- Sirtuins and Resveratrol in Medicine 2

Co-authors: Viviane Tabar (9 shared papers)C. David Allis (2 shared papers)Peter W. Lewis (1 shared paper)Tamara Major (1 shared paper)Tetsu Akiyama (6 shared papers)Yuhki Saito (2 shared papers)Yusuke Yamazumi (2 shared papers)Yasushi Ino (4 shared papers)
Journals: Oncogene (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Research (1 paper)Analytical Chemistry (1 paper)Science (1 paper)
Partner nations: United States Japan Switzerland

In The Last Decade

Kosuke Funato

14 papers receiving 638 citations

Peers

Countries citing papers authored by Kosuke Funato

Since Specialization

Citations

This map shows the geographic impact of Kosuke Funato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Funato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Funato more than expected).

Fields of papers citing papers by Kosuke Funato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Funato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Funato. The network helps show where Kosuke Funato may publish in the future.

Co-authors

The 25 scholars most cited alongside Kosuke Funato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kosuke Funato Line = papers co-authored together Kosuke Funato links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation Science ·Kosuke Funato, Tamara Major, Peter W. Lewis, C. David Allis, Viviane Tabar	2014	276
2	Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma Cell stem cell ·Kosuke Funato, Ryan C. Smith, Yuhki Saito, Viviane Tabar	2021	45
3	Target identification reveals lanosterol synthase as a vulnerability in glioma Proceedings of the National Academy of Sciences ·Richard E. Phillips, Yanhong Yang, Ryan C. Smith, Bonne M. Thompson, Tomoko Yamasaki, Yadira M. Soto-Feliciano, Kosuke Funato, Yupu Liang, Javier García‐Bermúdez, Xiaoshi Wang, Benjamin A. García, Kazuhiko Yamasaki, Jeffrey G. McDonald, Kıvanç Birsoy, Viviane Tabar, C. David Allis	2019	45
4	The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells Oncogene ·Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Tomoki Todo, Yasushi Ino, Nobuhito Saito, Hiroyuki Aburatani, Kosuke Funato, Kanae Echizen, Haruo Sugano, R Haruta, M. Matsui, Rina Takahashi, E Manabe, Takeaki Oda, Tetsu Akiyama	2012	42
5	SIRT 2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity EMBO Reports ·Kosuke Funato, Tomoatsu Hayashi, Kanae Echizen, Lumi Negishi, Naomi Shimizu, Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Yasuyuki Morishita, Viviane Tabar, Tomoki Todo, Yasushi Ino, Akitake Mukasa, Nobuhito Saito, Tetsu Akiyama	2018	41
6	Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44 Experimental and Therapeutic Medicine ·Kosuke Funato, Yusuke Yamazumi, Takeaki Oda, Tetsu Akiyama	2011	39
7	Adult Human Glioblastomas Harbor Radial Glia-like Cells Stem Cell Reports ·Rong Wang, Roshan Sharma, Xiaojuan Shen, Ashley M. Laughney, Kosuke Funato, P. J. Clark, Monika Shpokayte, Peter Morgenstern, Monalisa Navare, Yichi Xu, Shaghayegh Harbi, Ignas Masilionis, Gouri J. Nanjangud, Yanhong Yang, Gabriel Duran-Rehbein, Martin Hemberg, Dana Pe’er, Viviane Tabar	2020	36
8	The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells Oncogene ·Ryo Koyama‐Nasu, R Haruta, Yukiko Nasu‐Nishimura, Kenzui Taniue, Yuka KATOU, Katsuhiko Shirahige, Tomoki Todo, Yasushi Ino, Akitake Mukasa, Nobuhito Saito, M. Matsui, Rina Takahashi, Akemi Hoshino-Okubo, Haruo Sugano, E Manabe, Kosuke Funato, Tetsu Akiyama	2013	30
9	The RNA Binding Protein Mex-3B Is Required for IL-33 Induction in the Development of Allergic Airway Inflammation Cell Reports ·Yusuke Yamazumi, Oh Sasaki, Mitsuru Imamura, Takeaki Oda, Yoko Ohno, Yumi Shiozaki-Sato, Shigenori Nagai, Saki Suyama, Yuki Kamoshida, Kosuke Funato, Teruhito Yasui, Hitoshi Kikutani, Kazuhiko Yamamoto, Makoto Dohi, Shigeo Koyasu, Tetsu Akiyama	2016	29
10	Histone Mutations in Cancer Kosuke Funato, Viviane Tabar	2017	20
11	Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma Cancer Gene Therapy ·Martin J. Hicks, Kosuke Funato, Lin Wang, Eric Aronowitz, Jonathan P. Dyke, Douglas Ballon, David F. Havlicek, E Frenk, Bishnu P. De, Marı́a J. Chiuchiolo, Dolan Sondhi, Neil R. Hackett, Stephen M. Kaminsky, Viviane Tabar, R G Crystal	2014	18
12	Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma PLoS ONE ·Martin J. Hicks, Marı́a J. Chiuchiolo, Douglas Ballon, Jonathan P. Dyke, Eric Aronowitz, Kosuke Funato, Viviane Tabar, David F. Havlicek, Fan Fan, Dolan Sondhi, Stephen M. Kaminsky, Ronald G. Crystal	2016	17
13	NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells Proceedings of the National Academy of Sciences ·Yuhki Saito, Yanhong Yang, Misa Saito, Christopher Y. Park, Kosuke Funato, Viviane Tabar, Robert B. Darnell	2024	2
14	Abstract LB-104: The histone deacetylase SIRT2 regulates the cell proliferation and tumorigenicity of glioblastoma cancer stem cells Cancer Research ·Kosuke Funato, Yukiko Nasu‐Nishimura, Kanae Echizen, Tomoki Todo, Yasushi Ino, Nobuhito Saito, Ryo Koyama‐Nasu, Takeaki Oda, Tetsu Akiyama	2011	1
15	Quantitative HILIC-Q-TOF-MS Analysis of Glycosaminoglycans and Non-reducing End Carbohydrate Biomarkers via Glycan Reductive Isotopic Labeling Analytical Chemistry ·Amrita Basu, Stephanie Archer‐Hartmann, Pradeep Chopra, Mehrnoush Taherzadeh Ghahfarrokhi, Xiaolin Dong, Neil Patel, Yiwen Zhang, Biswa Choudhury, Kosuke Funato, Dhananjay Yellajoshyula, Geert‐Jan Boons, Parastoo Azadi, Ryan J. Weiss	2025	0
16	A human embryonic stem cell–based model reveals the cell of origin of FOXR2-activated CNS neuroblastoma Neuro-Oncology Advances ·Hitomi Royston, Autumn Hampton, Dhruv Bhagat, Evonne F Pinto, Miriam Emerson, Kosuke Funato	2024	0

About Kosuke Funato

Kosuke Funato is a scholar working on Genetics, Geriatrics and Gerontology, Cancer Research, Immunology and Cell Biology, having authored 16 papers that have together received 641 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Virus-based gene therapy research (3 papers), Sirtuins and Resveratrol in Medicine (2 papers), Epigenetics and DNA Methylation (2 papers), RNA Research and Splicing (2 papers), Glycosylation and Glycoproteins Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Genetics (218 citations), Cancer Research (146 citations), Geriatrics and Gerontology (25 citations), Molecular Biology (436 citations) and Developmental Neuroscience (22 citations). Kosuke Funato has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Viviane Tabar, C. David Allis, Peter W. Lewis, Tamara Major, Tetsu Akiyama, Yuhki Saito, Yusuke Yamazumi, Yasushi Ino, Yukiko Nasu‐Nishimura and Nobuhito Saito. Their work appears in journals such as Oncogene, Proceedings of the National Academy of Sciences, Cancer Research, Analytical Chemistry and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact